DOI QR코드

DOI QR Code

당뇨환자에서 자가관리형 베타케톤검사의 유효성: 체계적 문헌 고찰 및 메타분석

The Effectiveness of Blood β-ketone Testing in Patients with Diabetic Ketosis: A Systematic Review & Meta-analysis

  • 모진아 (한국보건의료연구원, 인하대학교 간호학과) ;
  • 장선영 (한서대학교 간호학과) ;
  • 방희영 (한국보건의료연구원)
  • Mo, Jin A (National Evidence-based Healthcare Collaborating Agency, Department of Nursing Inha University) ;
  • Jang, Sunyoung (Department of Nursing, Hanseo University) ;
  • Bang, Hee Young (National Evidence-based Healthcare Collaborating Agency)
  • 투고 : 2014.06.27
  • 심사 : 2014.08.14
  • 발행 : 2014.10.01

초록

Objectives: The effectiveness of Blood ${\beta}$-ketone testing by using self-monitoring strip on diabetic patients. Methods: Clinical effectiveness of blood ${\beta}$-ketone testing was assessed through correlation with reference test that measured blood ${\beta}$-ketone value through gas chromatography or enzyme method, diagnostic accuracy, time taken for the test and time taken for confirmative diagnosis of diabetic ketosis by selecting literatures on researches that conducted this test on ketosis(suspected) patients or diabetic ketosis(suspected) patients. Each of the stages from literature search to application of selection standards and extraction of data were carried out independently by the Subcommittee along with 2 researchers. Results: 7 reports were selected. ${\beta}$-ketone testing displayed high level of correlation in the range of r=0.92~0.99 with test using enzyme method as the reference standard. Regarding the diagnostic accuracy, sensitivity of 0.82, specificity of 0.74. The time taken for the test was 30seconds for the index test, which is shorter than reference standard test. Conclusion: Blood ${\beta}$-ketone testing was assessed to be a safe and effective test to monitor ketosis and assess the level of risk of ketosis by measuring the blood ${\beta}$-ketone on ketosis patients and diabetic ketosis patients since it has high level of correlation with reference test and short period of testing.

키워드

참고문헌

  1. American Diabetes Association. (2010). Standards of medical care in diabetes-2010. Diabetes Care, 33(1), 11-69.
  2. Bektas F. E., Eray O., Sari R., Akbas H. (2004). Point of care blood ketone testing of diabetic patients in the emergency department, Endocr Res, 30, 395-402. https://doi.org/10.1081/ERC-200035231
  3. Canadian Diabetes Association. (2008). Clinical Practice Guideline Expert Committee. Hyperglycemic Emergencies in Adults. Canadian J Diabetes 32(1), 65-70.
  4. Chiu R. W. H., Ho C. S., Tong S. F., Ng K. F., Lam C. W. (2002). Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration, Hong Kong med J, 8, 172-176.
  5. Deeks JJ. (2011). Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-162.
  6. Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986. https://doi.org/10.1056/NEJM199309303291401
  7. Guerci B., Benichou M., Floriot M., Bohme P., Fougnot S., Franck P., et al. (2003). Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients, Diabetes Care, 26, 1137-1141. https://doi.org/10.2337/diacare.26.4.1137
  8. Ham M. R. O., Okada P., White P. C. (2004). Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting, Pediatr Diabetes, 5, 39-43. https://doi.org/10.1111/j.1399-543X.2004.00032.x
  9. Health Insurance Review Agency. (2005). A Study on the Construction and Management of Health Technology Assessment System, Seoul: Health Insurance Review Agency, 227-228, in Korean.
  10. Higgins J. P. T., Green S. (2011). Cochrane handbook for systematic reviews of interventions 5.1.0(ed), United Kingdom: The Cochrane Collaboration, 33-49.
  11. International Diabetes Federation. Clinical Guideline Task Force. (2012). Global guide line for type 2 diabetes. Brussels: International Diabetes Federation. 32-100.
  12. Jung H. W., Park I. K. (2012). Evaluation of the Clinical Significance of Ketonuria, Lab Med Online, 2, 15-19. https://doi.org/10.3343/lmo.2012.2.1.3
  13. Khan KS, Kunz R, Kleijnen J, Antes G; Royal Society of Medi-cine (Great Britain). (2011). Systematic reviews to support evidence-based medicine: how to review and apply findings of health-care research. 2nd ed. London: Royal Society of Medicine; 2011. 201p.
  14. Kitabchi A. E., Umpierrez G. E., Miles J. M., Fisher J. N. (2009). Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 32, 1335-1343, 2009 https://doi.org/10.2337/dc09-9032
  15. Kitabchi A. E., Umpierrez G. E., Murphy M. B., Barrett E. J., Kreisberg R. A., Malone J. I. (2004). American Diabetes Association, Hyperglycemic crises in diabetes, Diabetes Care 27, 94-102. https://doi.org/10.2337/diacare.27.2007.S94
  16. Korea Centers for Disease Control and Prevention. (2011). Korea health statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Chungcheongbuk-do, Korea: Author.
  17. Ministry of Health and Welfare. (2011). Ministry of Health and Welfare Year Book 2011. Retrieved from http://stat.mw.go.kr/stat
  18. National Health Insurance Corporation. (2010). Health insurance statistical yearbook 2010. Retrieved from http://www.nhic.or.kr/portal/site/main/menuitem
  19. Neumann H. P. H. Pheochromocytoma. In: Longo D. L., Fauci A., Kasper D. L., Hauser S. L., Jameson J. L., Loscalzo J., editors. (2012). Harrison's principles of internal medicine, 18th ed, New York: McGraw-Hill, 2962-2967.
  20. PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analysis). (2013). Retrieved from http://www.prisma-statement.org/news.htm
  21. PRISMA Group. In: Moher D., Liberati A., Tetzlaff J., Altman D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151, 264-269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
  22. Rewers A. M., McFann K., Chase H. P. (2006). Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children, Diabetes Technol Ther. 8, 671-676. https://doi.org/10.1089/dia.2006.8.671
  23. Samuelsson U., Ludvigsson J. (2002). When should determination of ketonemia be recommended?, Diabetes Technol Ther, 4, 645-650. https://doi.org/10.1089/152091502320798286
  24. Scottish Intercollegiate Guidelines Network. (2011). SIGN 50: a guideline developer's handbook. Scotland: NHS Quality Improvement, 52-92.
  25. UK Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [UKPDS 33]. Lancet, 352, 837-853. https://doi.org/10.1016/S0140-6736(98)07019-6
  26. Voulgari C., Tentolouris N. (2010). The performance of a glucose-ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room, Diabetes Technol Ther, 12, 529-535. https://doi.org/10.1089/dia.2010.0011
  27. Yoong N. W. C. (2008). Blood ketone testing in the clinical laboratory - Technical evaluation of test-strips, Singapore General Hospital Proceedings, 17, 88-93.